Will Medicare expand to cover weight loss drugs in 2025?
Existing Medicare Coverage for Weight Loss
Currently, Medicare breaks down weight loss coverage into categories, mainly focusing on obesity screening, management, and the provision of certain weight loss procedures like gastric bypass surgery. However, the pharmaceutical aspect remains somewhat elusive. Popular weight loss pills like Contrave, Qsymia, and Saxenda are generally not included in this coverage.
2025 Predictions for Medicare and Weight Loss Drugs
Looking forward to 2025, with the growing obesity epidemic in the United States, it can be expected that lawmakers and Medicare administrators will feel increased pressure to adapt and enhance coverage. Weight loss drugs offer a potential solution to chronic obesity, thus saving long term health expenses. The inclusion of weight loss drugs within Medicare's coverage may, therefore, become a serious consideration.
Choosing Weight Loss Programs Covered by Medicare
Several weight loss programs have already received coverage by Medicare. These include certain types of bariatric surgeries and designated behavioral counseling programs. The choice among these can depend on individual health history, budget, and personal preferences. Always consult with a healthcare provider when considering these options.